Baseline characteristics

T-Cell Depleted Allogeneic Stem Cell Transplantation for Patients With Hematologic Malignancies · Source last updated 2016-11-22

Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.

denoms

1. counts

   1. group Id

      BG000

      value

      204

   units

   Participants

groups

1. description

   All patients were administered the following drugs; 1. Fludarabine 30mg/m2 intravenously daily at the same time over 30 min on days -7,-6,-5,-4, and -3 2. Melphalan 140mg/m2 IV on day -2 3. Stem cell infusion on day 0 4. Campath 20mg IV on day -7,-6,-5,-4, and -3

   id

   BG000

   title

   T-cell Depleted Allogeneic Stem Cell Transplantation

measures

1. classes

   1. categories

      1. measurements

         1. group Id

            BG000

            spread

            12.0

            value

            51.0

   dispersion Type

   STANDARD_DEVIATION

   param Type

   MEAN

   title

   Age, Continuous

   unit Of Measure

   years

2. classes

   1. categories

      1. measurements

         1. group Id

            BG000

            value

            93

         title

         Female

      2. measurements

         1. group Id

            BG000

            value

            111

         title

         Male

   param Type

   COUNT_OF_PARTICIPANTS

   title

   Sex: Female, Male

   unit Of Measure

   Participants

Download exact source JSON → · Snapshot ctgov-results-25a395029948b04d52b1253f

Preserved source evidence · Not medical advice